AAIC 2025 Abstract·23 DecMINDFuL: a Multi‐center, Randomized, Double‐blind, Placebo‐controlled Phase 2 Clinical Trial of XPro1595 for Patients with Early Alzheimer's Disease and Biomarkers of InflammationTrial in peopleInterventionsPaper